Tobi Arisa completed his B.A Medicinal Chemistry degree in 2017 at Trinity College, Dublin. During the summer of his final year, Tobi carried out a research project focused on the synthesis of peptides using a novel ligation technique where I adopted a host of techniques. This project was supervised by Professor Eoin Scanlan. Additionally, working with the Scanlan group, Tobi was able to make considerable progress in his research project and synthesised compounds that are being used as part of a study on the role of lipoproteins of Pseudomonas aeruginosa on pathogenesis and disease. Tobi’s final year research project supervised by Professor Thorfinnur Gunnlaugsson of Trinity college Dublin was based on the Synthesis, Photophysical and Biological evaluation of 4-amino-1,8-naphthalimides based Tröger’s base as DNA targeting agents and potential anti-cancer agents. This project incorporated the use of 4-amino-1,8-naphthalimides based Tröger’s bases as probes, pH sensors and cytotoxic compounds in cells.
Sandrine Hell completed her bachelor’s degree both at the Albert-Ludwigs University (Germany) and Haute-Alsace University (France). She was awarded both her master’s and chemical engineering degrees from the Haute-Alsace University (France) and the National Engineer school of Mulhouse (France). During the first year of her master’s degree, she collaborated with Prof Andrew Whiting (Durham University, UK), working on a project involving the synthesis of synthetic fluorescent retinoid derivatives for use in biological and imaging applications. For her masters thesis Sandrine has conducted work at the pharmaceutical company Galapagos (Paris), on the synthesis of new scaffolds and generation of libraries.
Claudio Meyer was born in 1994 in Basel, Switzerland. He studied Chemistry at the University of Basel, where he obtained his BSc in 2016. He began his master studies in summer 2016 and then went on to join the research group of Prof. Matthias Wymann, working in collaboration with PIQUR Therapeutics on the synthesis of inhibitors of lipid kinases as anti-cancer agents.
Back to top
Tim A. Mollner
Tim is from North-Rhine-Westphalia in the West of Germany and completed his undergraduate studies at Martin-Luther University Halle-Wittenberg. He then graduated in 2017 with a First Class M.Sc. from the Technical University of Munich. For his Master’s thesis Tim visited the Helmholtz-Centre for Infection Research in Braunschweig, Germany, working on the synthesis of novel antibacterial Cystobactamide derivatives under the supervision of Prof Mark Brönstrup.
Giulia Roagna completed her Master degree in Chemistry and Pharmaceutical Technologies in 2014 at the University of Turin, Italy. In the same year, she carried out an Industrial Placement in the Swedish start-up company Red Glead Discovery under the supervision of Dr. Johan Evenas. During the past 2 years, she has been working at AstraZeneca Göteborg as part of their Innovative Medicine & Early Development graduate program. She has been focusing on the synthesis of small molecules for medicinal chemistry and peptide and conjugation chemistry. Since she joined the structure and biophysics team, Giulia has been developing novel screening paradigms employing surface plasmon resonance and single molecule microscopy.
Back to top